Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counter (OTC) Portfolio with the acquisition of approved ANDAs from Wockhardt Limited
MUMBAI, India and MAHWAH, N.J., June 28, 2022 /PRNewswire/ — Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharmaceutical company, announced that
Read More